Akademik Veri Yönetim Sistemi
Annals of Medical Research, cilt.27, sa.10, ss.2695-2700, 2020 (Hakemli Dergi)
Abstract
Aim: The aim of study was to examine the results of percutaneous cholecystostomy (PC) in high-risk patients with acute cholecystitis
(AC).
Material and Methods: In the retrospective study, records of patients with PC were examined. An American Society of Anesthesiologists
(ASA) score was used for surgical risk. AC severity was evaluated according to Tokyo guidelines (TG) 18. TG 18 grade III, TG 18 grade
II and I high surgical risk patients with AC were included in the study. Risk factors affecting the success of PC were investigated.
Results: Seventy patients were included in the study. The median folllow-up time was eight (1-119) months. The clinical success
rate of PC and rate of recurrence were 85.7% and 10.0%, respectively. PC catheter-related complications were occurred at four
patients. The mortality rate was 14.3%. An ASA ≥ IV score (p=0.005), chronic obstructive pulmonary disease (p=0.04), elevation
in total bilirubin (p=0.02), and duration of PC <14 days (p <0.001) were found to be risk factors reducing the success of PC. In the
logistic regression analysis, an ASA ≥ IV score (p=0.03) and duration of PC <14 days (p=0.005) were found to be independent risk
factors reducing the success of PC.
Conclusion: PC can be used safely in high-risk patients with AC. The PC catheter should not be removed in <14 days and surgical
treatment should be considered for patients with ASA ≥ IV score.
Keywords: Cholecystectomy; definitive treatment; efficacy; morbidity; mortality; percutaneous cholecystostomy